ES2001950A6 - Procedimiento de obtencion de composiciones en emulsion para la administracion de farmacos hidrofobos ionizables escasamente hidrosolubles. - Google Patents
Procedimiento de obtencion de composiciones en emulsion para la administracion de farmacos hidrofobos ionizables escasamente hidrosolubles.Info
- Publication number
- ES2001950A6 ES2001950A6 ES8601758A ES8601758A ES2001950A6 ES 2001950 A6 ES2001950 A6 ES 2001950A6 ES 8601758 A ES8601758 A ES 8601758A ES 8601758 A ES8601758 A ES 8601758A ES 2001950 A6 ES2001950 A6 ES 2001950A6
- Authority
- ES
- Spain
- Prior art keywords
- administration
- water soluble
- sparingly water
- emulsion compositions
- hydrophobic drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Colloid Chemistry (AREA)
Abstract
PROCEDIMIENTO DE OBTENCION DE COMPOSICIONES EN EMULSION PARA LA ADMINISTRACION DE FARMACOS HIDROFOBOS IONIZABLES ESCASAMENTE HIDROSOLUBLES, MEDIANTE REACCION DEL FARMACO HIDROFOBO CON UN FORMADOR DE PAR IONICO Y FORMACION DE UNA EMULSION, ACEITE EN AGUA DEL PAR IONICO RESULTANTE, ELIGIENDOSE EL FORMADOR DE PAR IONICO ENTRE ACIDOS ALIFATICOS O AROMATICOS SATURADOS O INSATURADOS C6-C20, CUANDO EL FARMACO HIDROFOBO SEA BASICO Y UNA AMINA ALIFATICA O AROMATICA ACEPTABLE CUANDO EL FARMACO HIDROFOBO SEA ACIDO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/774,762 US4816247A (en) | 1985-09-11 | 1985-09-11 | Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2001950A6 true ES2001950A6 (es) | 1988-07-01 |
Family
ID=25102201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES8601758A Expired ES2001950A6 (es) | 1985-09-11 | 1986-09-10 | Procedimiento de obtencion de composiciones en emulsion para la administracion de farmacos hidrofobos ionizables escasamente hidrosolubles. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4816247A (es) |
EP (1) | EP0214501B1 (es) |
JP (1) | JPS62111915A (es) |
KR (1) | KR900000211B1 (es) |
AT (1) | ATE80795T1 (es) |
AU (1) | AU593014B2 (es) |
CA (1) | CA1272685A (es) |
DE (1) | DE3686797T2 (es) |
DK (1) | DK432586A (es) |
ES (1) | ES2001950A6 (es) |
FI (1) | FI86142C (es) |
GR (1) | GR862316B (es) |
HU (1) | HU196700B (es) |
IE (1) | IE59828B1 (es) |
NO (1) | NO171145C (es) |
NZ (1) | NZ217483A (es) |
PH (1) | PH24313A (es) |
ZA (1) | ZA866899B (es) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4784845A (en) * | 1985-09-16 | 1988-11-15 | American Cyanamid Company | Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs |
US6759057B1 (en) * | 1986-06-12 | 2004-07-06 | The Liposome Company, Inc. | Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs |
US5229422A (en) * | 1987-09-07 | 1993-07-20 | Teijin Limited | Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion |
US5244925A (en) * | 1987-12-18 | 1993-09-14 | Kabi Pharmacia Aktiebolag | Emulsion for parenteral administration |
JP2643217B2 (ja) * | 1988-01-22 | 1997-08-20 | エーザイ株式会社 | 脂溶性物質水性液 |
DE3902079A1 (de) * | 1988-04-15 | 1989-10-26 | Bayer Ag | I.m. injektionsformen von gyrase-inhibitoren |
GB2217596A (en) * | 1988-04-26 | 1989-11-01 | American Cyanamid Co | Anti-arthritic liposome composition |
DE68914929T2 (de) * | 1988-09-29 | 1994-08-11 | Shiseido Co Ltd | Emulgierte Zusammensetzung. |
US4971788A (en) * | 1989-01-27 | 1990-11-20 | Medicontrol Corporation | Oral cavity and dental microemulsion products |
DE3908047A1 (de) * | 1989-03-13 | 1990-09-20 | Desitin Arzneimittel Gmbh | Hochdisperse pharmazeutische zusammensetzung |
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
GB8919172D0 (en) * | 1989-08-23 | 1989-10-04 | Univ Nottingham | Useful composition |
US5221535A (en) * | 1989-11-13 | 1993-06-22 | Nova Pharmaceutical Corporation | Sustained release formulations of insect repellent |
US5188837A (en) * | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
US5227165A (en) * | 1989-11-13 | 1993-07-13 | Nova Pharmaceutical Corporation | Liposphere delivery systems for local anesthetics |
IE904098A1 (en) * | 1989-11-13 | 1991-05-22 | Nova Pharm Corp | Lipospheres for controlled delivery of substances |
JPH0714872B2 (ja) * | 1990-02-06 | 1995-02-22 | 昭和薬品化工株式会社 | シロップ剤組成物 |
DE4015108A1 (de) * | 1990-05-11 | 1991-11-14 | Leopold Pharma Gmbh | Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe |
DE4124252A1 (de) * | 1991-07-22 | 1993-01-28 | Knoll Ag | Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung |
GB2260079B (en) * | 1991-10-01 | 1995-08-09 | American Cyanamid Co | Pharmaceutical composition containing felbinac |
JPH06157294A (ja) * | 1992-11-19 | 1994-06-03 | Tanabe Seiyaku Co Ltd | 脂肪微粒子製剤 |
SG65599A1 (en) * | 1993-03-24 | 1999-06-22 | Collaborative Lab Inc | Cosmetic delivery system for salicylic acid and process for preparation of same |
US5969004A (en) * | 1993-10-15 | 1999-10-19 | The Gillette Company | Aqueous inks |
US5851510A (en) * | 1994-05-16 | 1998-12-22 | The Board Of Regents Of The University Of Michigan | Hepatocyte-selective oil-in-water emulsion |
WO1996003113A1 (en) * | 1994-07-22 | 1996-02-08 | G.D. Searle & Co. | Self-emulsifying drug delivery system |
US5616342A (en) * | 1995-04-11 | 1997-04-01 | Pdt, Inc. | Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
GB9625589D0 (en) | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
US6054421A (en) * | 1997-09-23 | 2000-04-25 | Scimed Life Systems, Inc. | Medical emulsion lubricant |
US6281175B1 (en) | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
CN1239158C (zh) * | 1997-09-30 | 2006-02-01 | 伊莱利利公司 | 2-甲基-噻吩并-苯并二氮杂䓬制剂 |
TWI241915B (en) | 1998-05-11 | 2005-10-21 | Ciba Sc Holding Ag | A method of preparing a pharmaceutical end formulation using a nanodispersion |
US6682758B1 (en) | 1998-12-22 | 2004-01-27 | The United States Of America As Represented By The Department Of Health And Human Services | Water-insoluble drug delivery system |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
WO2001085142A1 (en) | 2000-05-05 | 2001-11-15 | Wisconsin Alumni Research Foundation | Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
MXPA03000720A (es) * | 2000-07-24 | 2004-11-01 | Upjohn Co | Sistemas auto-emulsificantes de suministro de medicamentos para medicamentos lipofilicos extremadamente insolubles en agua. |
AU2002363959B2 (en) * | 2001-12-03 | 2007-12-13 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
WO2003097026A1 (fr) * | 2002-05-22 | 2003-11-27 | Nihon Pharmaceutical Co., Ltd. | Inhibiteur du peristaltisme de muscles lisses |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US10172810B2 (en) | 2003-02-24 | 2019-01-08 | Pharmaceutical Productions, Inc. | Transmucosal ketamine delivery composition |
JP5475215B2 (ja) | 2003-02-24 | 2014-04-16 | ファーマシューティカル プロダクションズ, インコーポレイテッド | 経粘膜薬物送達システム |
US9498454B2 (en) | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
US20050020546A1 (en) * | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
US7871632B2 (en) * | 2004-07-12 | 2011-01-18 | Adventrx Pharmaceuticals, Inc. | Compositions for delivering highly water soluble drugs |
US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
WO2006073886A1 (en) | 2005-01-05 | 2006-07-13 | Eli Lilly And Company | Olanzapine pamoate dihydrate |
TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
EP2200613B1 (en) | 2007-09-21 | 2018-09-05 | The Johns Hopkins University | Phenazine derivatives and uses thereof |
BRPI0801417B8 (pt) * | 2008-03-13 | 2021-05-25 | Univ Minas Gerais | processo para obtenção de composição farmacêutica de retinóides, produto derivado de retinóides e uso |
US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
JP5468221B2 (ja) * | 2008-08-04 | 2014-04-09 | 株式会社 メドレックス | 難溶性薬物の静注用分散製剤 |
JP5619780B2 (ja) | 2009-02-26 | 2014-11-05 | テイコク ファーマ ユーエスエー インコーポレーテッド | 癌性疼痛の治療のための麻薬性エマルション製剤 |
GB201009676D0 (en) | 2010-06-10 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel process |
WO2015013581A1 (en) | 2013-07-26 | 2015-01-29 | Update Pharma Inc. | Combinatorial methods to improve the therapeutic benefit of bisantrene |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172816A (en) * | 1963-01-28 | 1965-03-09 | Smith Kline French Lab | Method of increasing the oil solubility of compounds and products thereof |
US3647624A (en) * | 1969-07-24 | 1972-03-07 | Wisconsin Alumni Res Found | Treatment of blood with oleaginous substance |
JPS5021334B1 (es) * | 1970-11-04 | 1975-07-22 | ||
US4124720A (en) * | 1970-11-09 | 1978-11-07 | Wenmaekers Georges E J | Therapeutic hydrodispersible emulsion |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
FR2313078A1 (fr) * | 1975-02-07 | 1976-12-31 | Anvar | Composition a base d'huile vegetale metabolisable et d'eau, utilisable notamment pour la constitution de preparations adjuvantes, ces preparations adjuvantes et leur procede d'obtention |
US3991206A (en) * | 1976-01-15 | 1976-11-09 | American Cyanamid Company | Alleviation of eye inflammation by topical application of p-biphenylacetic acid |
US4168308A (en) * | 1976-03-12 | 1979-09-18 | Apoteksvarucentralen Vitrum Ab | Composition for enhancing the administration of pharmacologically active agents |
IN150729B (es) * | 1978-09-22 | 1982-11-27 | Lever Hindustan Ltd | |
US4340054A (en) * | 1980-12-29 | 1982-07-20 | Alza Corporation | Dispenser for delivering fluids and solids |
GB2105589B (en) * | 1981-09-11 | 1985-10-23 | Wellcome Found | Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent |
JPS5859912A (ja) * | 1981-10-06 | 1983-04-09 | Green Cross Corp:The | 鎮痛消炎物質脂肪乳剤 |
FR2520253A1 (fr) * | 1982-01-28 | 1983-07-29 | Oreal | Nouveau systeme emulsionnant a base d'un condensat de proteines, d'un sterol polyoxyethylene et de phosphatide et son utilisation en cosmetique |
JPS59134710A (ja) * | 1983-01-21 | 1984-08-02 | Suntory Ltd | 発酵養毛化粧料 |
US4563354A (en) * | 1983-10-26 | 1986-01-07 | Kabivitrum Ab | Oil-in-water emulsion for parenteral administration |
US4703062A (en) * | 1984-01-16 | 1987-10-27 | Baxter Travenol Laboratories, Inc. | Parenteral nutrition with medium and long chain triglycerides |
US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | 4−ビフエニリル酢酸系化合物含有脂肪乳剤 |
NZ213008A (en) * | 1984-08-22 | 1989-04-26 | Mobil Oil Corp | Grease compositions containing diol/boron compound reaction products |
US4797288A (en) * | 1984-10-05 | 1989-01-10 | Warner-Lambert Company | Novel drug delivery system |
US4784845A (en) * | 1985-09-16 | 1988-11-15 | American Cyanamid Company | Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs |
-
1985
- 1985-09-11 US US06/774,762 patent/US4816247A/en not_active Expired - Fee Related
-
1986
- 1986-08-16 EP EP86111325A patent/EP0214501B1/en not_active Expired - Lifetime
- 1986-08-16 DE DE8686111325T patent/DE3686797T2/de not_active Expired - Fee Related
- 1986-08-16 AT AT86111325T patent/ATE80795T1/de active
- 1986-09-05 NZ NZ217483A patent/NZ217483A/xx unknown
- 1986-09-09 CA CA000517737A patent/CA1272685A/en not_active Expired - Fee Related
- 1986-09-10 FI FI863664A patent/FI86142C/fi not_active IP Right Cessation
- 1986-09-10 PH PH34241A patent/PH24313A/en unknown
- 1986-09-10 DK DK432586A patent/DK432586A/da not_active Application Discontinuation
- 1986-09-10 ES ES8601758A patent/ES2001950A6/es not_active Expired
- 1986-09-10 ZA ZA866899A patent/ZA866899B/xx unknown
- 1986-09-10 HU HU863901A patent/HU196700B/hu not_active IP Right Cessation
- 1986-09-10 NO NO863620A patent/NO171145C/no unknown
- 1986-09-10 AU AU62538/86A patent/AU593014B2/en not_active Ceased
- 1986-09-10 GR GR862316A patent/GR862316B/el unknown
- 1986-09-10 KR KR1019860007580A patent/KR900000211B1/ko not_active IP Right Cessation
- 1986-09-10 IE IE240886A patent/IE59828B1/en not_active IP Right Cessation
- 1986-09-11 JP JP61214969A patent/JPS62111915A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU593014B2 (en) | 1990-02-01 |
NO171145C (no) | 1993-02-03 |
EP0214501A3 (en) | 1987-09-09 |
KR900000211B1 (ko) | 1990-01-23 |
NO863620L (no) | 1987-03-12 |
NO171145B (no) | 1992-10-26 |
DE3686797D1 (de) | 1992-10-29 |
ZA866899B (en) | 1987-05-27 |
EP0214501A2 (en) | 1987-03-18 |
KR870002834A (ko) | 1987-04-13 |
ATE80795T1 (de) | 1992-10-15 |
NZ217483A (en) | 1990-08-28 |
NO863620D0 (no) | 1986-09-10 |
IE59828B1 (en) | 1994-04-06 |
PH24313A (en) | 1990-05-29 |
FI863664A0 (fi) | 1986-09-10 |
DE3686797T2 (de) | 1993-03-25 |
HU196700B (en) | 1989-01-30 |
DK432586A (da) | 1987-03-12 |
FI863664A (fi) | 1987-03-12 |
IE862408L (en) | 1987-03-11 |
DK432586D0 (da) | 1986-09-10 |
AU6253886A (en) | 1987-03-12 |
EP0214501B1 (en) | 1992-09-23 |
FI86142C (fi) | 1992-07-27 |
JPS62111915A (ja) | 1987-05-22 |
US4816247A (en) | 1989-03-28 |
CA1272685A (en) | 1990-08-14 |
HUT43948A (en) | 1988-01-28 |
GR862316B (en) | 1987-01-13 |
FI86142B (fi) | 1992-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2001950A6 (es) | Procedimiento de obtencion de composiciones en emulsion para la administracion de farmacos hidrofobos ionizables escasamente hidrosolubles. | |
MX171191B (es) | Composiciones farmaceuticas de glipizida | |
MX9700081A (es) | Composiciones farmaceuticas de tacrina. | |
EP1033981A4 (en) | FORMULATIONS AND METHODS FOR REDUCING THE TOXICITY OF ANTINEOPLASTIC AGENTS | |
EP0724885A4 (en) | COMPOSITION ADMINISTERED BY NASAL AND PREPARATION CONTAINING THE SAME | |
NO306377B1 (no) | Doseform for avgivelse av et medikament | |
ZA867009B (en) | Emulsion compositions for the parenteral and/or oral administration of sparingly water soluble ionizable hydrophobic drugs | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
KR910019618A (ko) | 발기부전증 치료용 제약 조성물 | |
WO2003049694A3 (en) | Methods of therapy for non-hodgkin's lymphoma | |
KR970025615A (ko) | 암 전이 억제제 | |
ES2119748T3 (es) | Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua. | |
IL78336A (en) | Compositions for delivery of orally administered fat-soluble drugs | |
ATE234082T1 (de) | Adenosin enthaltendes arzneimittel | |
DE3263832D1 (en) | Gallium chloride, an anti-cancer drug | |
MY100780A (en) | Azumolene dosage form. | |
ES2062763T3 (es) | Preparacion farmaceutica de 1-octadecil-2-metil-glicero-3-fosfocolina administrable por via intravenosa. | |
SE7708622L (sv) | 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem | |
KR870005642A (ko) | 디플루니살과 트로메타민의 혼합물 | |
RU94020614A (ru) | Противоопухолевое средство | |
IT1262929B (it) | Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici | |
UA30251A (uk) | Спосіб лікування гіпертонії сфінктера одді у хворих на хронічний безкам'яний холецистит при поєднанні з підвищенням тонусу симпатичної нервової системи |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SA6 | Expiration date (snapshot 920101) |
Free format text: 2006-09-10 |